Literature DB >> 23465506

The relationship of serum triglycerides, serum HDL, and obesity to the risk of wheezing in 85,555 adults.

R V Fenger1, A Gonzalez-Quintela, A Linneberg, L L N Husemoen, B H Thuesen, M Aadahl, C Vidal, T Skaaby, J C Sainz, E Calvo.   

Abstract

BACKGROUND: Asthma has been linked to obesity and the presence of the metabolic syndrome.
OBJECTIVE: To explore which components of the metabolic syndrome that were associated with wheezing, a main symptom of asthma. Further, to explore whether these associations were different in individuals with and without rhinitis symptoms.
METHODS: We used data from the Ibermutuamur Cardiovascular Risk Assessment Plan (ICARIA) including 85,555 Spanish workers (median age = 34, range = 16-75 years) with assessments of self reported wheezing and rhinitis symptoms. Fasting blood samples were analysed for serum triglyceride (s-TG), HDL (s-HDL) and glucose; blood pressure, waist circumference (WC) and body mass index (BMI) were measured.
RESULTS: In mutually adjusted analyses including all components of the metabolic syndrome and possible confounders, elevated WC (or BMI), elevated s-TG and low s-HDL were significantly associated with wheezing. Odds ratio (OR) with confidence interval (CI) were: elevated WC = 1.54 (1.46-1.62), elevated s-TG = 1.24 (1.18-1.30), low s-HDL = 1.17 (1.12-1.22). These associations were stronger in individuals without than in those with rhinitis symptoms, OR's (CI's) were WC = without rhinitis 1.70 (1.57-1.85) vs. with rhinitis 1.47 (1.37-1.58). Elevated s-TG = without rhinitis 1.36 (1.26-1.46) vs. with rhinitis 1.21 (1.13-1.29). Low s-HDL = without rhinitis 1.24 (1.15-1.34) vs. with rhinitis 1.11 (1.04-1.18).
CONCLUSIONS: High s-TG and low s-HDL were associated with wheezing after adjustment for adiposity. This may substantiate elevated s-TG and lowered s-HDL as markers or inducers of inflammation associated disease. The study supports the notion that these biochemical markers have differential effects on different types of wheezing.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23465506     DOI: 10.1016/j.rmed.2013.02.001

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  20 in total

1.  Exploring the origins of asthma: Lessons from twin studies.

Authors:  Simon Francis Thomsen
Journal:  Eur Clin Respir J       Date:  2014-09-01

Review 2.  Pediatric Obesity-Related Asthma: The Role of Metabolic Dysregulation.

Authors:  Nandini Vijayakanthi; John M Greally; Deepa Rastogi
Journal:  Pediatrics       Date:  2016-04-08       Impact factor: 7.124

3.  Association of systemic inflammation, adiposity, and metabolic dysregulation with asthma burden among Hispanic adults.

Authors:  Deepa Rastogi; Molly Jung; Garrett Strizich; Pamela A Shaw; Sonia M Davis; Oana L Klein; Frank J Penedo; Andrew L Ries; Martha L Daviglus; Juan J Moreiras; Matthias A Salathe; Juan C Celedón; Carmen R Isasi; Robert C Kaplan
Journal:  Respir Med       Date:  2017-03-06       Impact factor: 3.415

Review 4.  Asthma and metabolic syndrome: Current knowledge and future perspectives.

Authors:  Laura Serafino-Agrusa; Mario Spatafora; Nicola Scichilone
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 5.  Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism.

Authors:  Michael B Fessler
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

6.  Glycated Hemoglobin A1c, Lung Function, and Hospitalizations Among Adults with Asthma.

Authors:  Ge Yang; Yueh-Ying Han; Erick Forno; Qi Yan; Franziska Rosser; Wei Chen; Juan C Celedón
Journal:  J Allergy Clin Immunol Pract       Date:  2020-06-20

7.  Association of pulmonary function with adiposity and metabolic abnormalities in urban minority adolescents.

Authors:  Deepa Rastogi; Kshitij Bhalani; Charles B Hall; Carmen R Isasi
Journal:  Ann Am Thorac Soc       Date:  2014-06

8.  Pediatric metabolic outcome comparisons based on a spectrum of obesity and asthmatic symptoms.

Authors:  Ashley D Perdue; Lesley A Cottrell; Christa L Lilly; William A Gower; Brian A Ely; Brad Foringer; Melvin L Wright; William A Neal
Journal:  J Asthma       Date:  2018-05-03       Impact factor: 2.515

9.  Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma.

Authors:  Amisha V Barochia; Maryann Kaler; Rosemarie A Cuento; Elizabeth M Gordon; Nargues A Weir; Maureen Sampson; Joseph R Fontana; Sandra MacDonald; Joel Moss; Vincent Manganiello; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

Review 10.  The Gut/Lung Microbiome Axis in Obesity, Asthma, and Bariatric Surgery: A Literature Review.

Authors:  Yeon Ji Kim; Jack T Womble; Claudia K Gunsch; Jennifer L Ingram
Journal:  Obesity (Silver Spring)       Date:  2021-04       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.